Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zelpultide alfa by Airway Therapeutics for Bronchopulmonary Dysplasia: Likelihood of Approval
Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Bronchopulmonary Dysplasia. According to GlobalData,...